|
KMID : 0931320140140020082
|
|
대한상부위장관.헬리코박터학회지
2014 Volume.14 No. 2 p.82 ~ p.86
|
|
|
Medical and Endoscopic Management of Achalasia
|
|
Han Jae-Pil
Hong Su-Jin
|
|
|
Abstract
|
|
|
|
Achalasia is a rare primary esophageal motility disorder. Because its etiology is uncertain, treatment is focused on palliation of symp-toms or for decreasing lower esophageal sphincter pressure. Treatment options include pharmacological, endoscopic and surgical methods. Various medications including nitrates, calcium channel blockers, and nitric oxide donors (sildenafil) are available, but their effectiveness is inconsistent. Endoscopic options include pneumatic balloon dilation, injection of botulinum toxin, temporary self-expandable metal stent placement, and peroral endoscopic myotomy. Laparoscopic or open myotomy can be a surgical option. We reviewed the treatment options focusing on medical and endoscopic management of achalasia.
|
|
|
KEYWORD
|
|
|
Esophageal achalasia, Endoscopic treatment, Medication
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|
|